Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Samama

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Thrombosis Research|February 15, 1996
Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole bloodG T Gerotziafas, L Bara, M F Bloch, et al.
La Revue De Medecine Interne|January 1, 1995
[Diagnosis of activated protein C resistance by chronometric test and molecular biology]M Trossaërt, N Pourkiani, J Conard, et al.
Haemostasis|October 1, 1996
Diagnosis and clinical characteristics of inherited activated protein C resistanceM M Samama, D Simon, M H Horellou, et al.
American Journal of Ophthalmology|October 15, 1994
A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutinA Glacet-Bernard, G Coscas, A Chabanel, et al.
Haemostasis|January 13, 2001
Thrombolysis and adjunctive therapies in acute myocardial infarctionG Helft, S G Worthley, A G Zaman, et al.
American Journal of Clinical Pathology|October 1, 1995
Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.
BMJ (Clinical Research Ed.)|October 17, 1992
Low molecular weight heparin in prevention of perioperative thrombosisA Leizorovicz, M C Haugh, F R Chapuis, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1995
[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.
Blood|December 15, 1995
Risk of thrombosis in patients homozygous for factor V LeidenM M Samama, M Trossaërt, M H Horellou, et al.
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Thrombosis Research|February 15, 1996
Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole bloodG T Gerotziafas, L Bara, M F Bloch, et al.
La Revue De Medecine Interne|January 1, 1995
[Diagnosis of activated protein C resistance by chronometric test and molecular biology]M Trossaërt, N Pourkiani, J Conard, et al.
Haemostasis|October 1, 1996
Diagnosis and clinical characteristics of inherited activated protein C resistanceM M Samama, D Simon, M H Horellou, et al.
American Journal of Ophthalmology|October 15, 1994
A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutinA Glacet-Bernard, G Coscas, A Chabanel, et al.
Haemostasis|January 13, 2001
Thrombolysis and adjunctive therapies in acute myocardial infarctionG Helft, S G Worthley, A G Zaman, et al.
American Journal of Clinical Pathology|October 1, 1995
Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.
BMJ (Clinical Research Ed.)|October 17, 1992
Low molecular weight heparin in prevention of perioperative thrombosisA Leizorovicz, M C Haugh, F R Chapuis, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1995
[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.
Blood|December 15, 1995
Risk of thrombosis in patients homozygous for factor V LeidenM M Samama, M Trossaërt, M H Horellou, et al.
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.
Pageof 19